Urology News and Research

Latest Urology News and Research

EMUC discusses current and future prospects in imaging for prostate cancer

At the 4th European Multidisciplinary Meeting on Urological Cancers (EMUC) held this weekend in Barcelona, Spain, specialists from radiology, urology, medical oncology and pathology said that new developments and research are already underway but benefits to patients would take some time due to the need for clinical trials, the high cost of funding research and the ability of cancer experts to efficiently take advantage of new insights and approaches, among other challenges.

19 Nov 2012

Loyola explores different prostate cancer websites for meaningful medical information

Prostate cancer, like many medical conditions, varies in presentation, treatment options, and outcomes. Undeniably, patients rely on the Internet for early education about their prostate cancer diagnosis or to fill information gaps from doctors. We use the Internet to research nearly every facet of our lives, and our physical wellbeing is no exception. But can we trust what we read? Better yet, can we understand it?

17 Nov 2012

Healthy ‘visual diet’ may help prevent eating disorders

A woman’s perception of her ideal body shape is strongly associated with the body mass index of women she sees in commonly viewed images such as those in magazines and on the television, show study findings.

15 Nov 2012

Adrenoreceptor shows potential in overactive bladder treatment

Mirabegron, a β3-adrenoreceptor agonist, has shown 12-month safety, tolerability, and persistence of effect in patients with overactive bladders, show study findings.

14 Nov 2012

Fasting before lipid testing may no longer be necessary

It may no longer be necessary for patients to fast before having their lipid levels tested, show study findings.

13 Nov 2012

National Association For Continence to host free educational events from Nov. 12 - 16

The National Association For Continence (NAFC) is hosting free educational events during National Bladder Health Week. Bladder Health Week occurs every year during the second full week in November. This year Bladder Health Week will be held from November 12 - 16.

7 Nov 2012

Duration of ibuprofen use may reduce risk of bladder cancer in northern New England patients

Dartmouth researchers have found that duration of ibuprofen use was associated with a reduced risk of bladder cancer in patients in northern New England, which has a high mortality rate of this disease. In a 2012 collaborative project with the National Cancer Institute, Margaret Karagas, PhD, co-director, Cancer Epidemiology & Chemoprevention program at Norris Cotton Cancer Center, and Professor of Community and Family Medicine at the Geisel School of Medicine at Dartmouth, and Richard Waddell, D.Sc, Research Assistant Professor of Medicine at the Geisel School of Medicine, looked for connections between ibuprofen use and bladder cancer.

7 Nov 2012

Study addresses cost of patient care in acute care surgical settings

An acute care surgery model led to improvement in the quality of surgical patient care and reduced the cost of emergency surgical care at Loma Linda University Medical Center, report researchers who published their findings in the November issue of the Journal of the American College of Surgeons.

7 Nov 2012

Taiho Pharmaceutical announces early stage data for eight novel oncology compounds

Taiho Pharmaceutical Co., Ltd., the developer of the first orally available fluorouracil (FU) Chemotherapeutic treatment (TS-1/S-1), is presenting early stage data for eight novel oncology compounds, including potential first-in-class therapies.

7 Nov 2012

Monoclonal antibody boosts cholesterol reduction

Adding a monoclonal antibody that blocks the breakdown of lipid receptors to atorvastatin therapy further reduces low-density lipoprotein cholesterol levels in patients with primary hypercholesterolemia, show study findings.

6 Nov 2012

Endo, Bioniche decide to end second Urocidin Phase III trial on non-muscle-invasive bladder cancer

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that a second Phase III clinical trial with Urocidin in non-muscle-invasive bladder cancer is being discontinued.

5 Nov 2012

Men with prostate cancer can benefit from active surveillance

With active surveillance many men with prostate cancer could dispense with radiation treatment and surgery, and thus avoid adverse effects such as incontinence and impotence. This is the outcome of a study of almost 1,000 men diagnosed with prostate cancer conducted at Sahlgrenska Academy, University of Gothenburg, Sweden.

3 Nov 2012

Toilet training method not related to urinary accidents in children

Parents: stop worrying about which toilet training method to use - where urinary accidents in children are concerned, it doesn't matter. This clearly-stated message, published today in Clinical Pediatrics by physician researchers from the University of Medicine and Dentistry of New Jersey (UMDNJ)-Robert Wood Johnson Medical School and The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital, emphasizes that the method of training chosen by parents is not the cause of urinary accidents in children.

3 Nov 2012

Imatinib mesylate effectively treats children with neurofibromatosis type 1 tumors

Physician-researchers at Indiana University School of Medicine have reported the first effective therapy for a class of previously untreatable and potentially life-threatening tumors often found in children.

2 Nov 2012

Multiple sclerosis disease activity reduced by leukaemia drug, even when first-line treatment has failed

A drug which was originally developed to treat leukaemia and other cancers of the immune system offers substantial improvements over existing treatments in reducing relapse rates for people with multiple sclerosis (MS), even when they have not responded well to first-line treatment, according to the results of two phase 3 trials published Online First in The Lancet.

1 Nov 2012

Encouraging results from stereotactic radiosurgery Phase I trial on kidney cancer

A first-of-its-kind clinical trial conducted at University Hospitals (UH) Case Medical Center Seidman Cancer Center has shown encouraging results for the use of stereotactic radiosurgery to treat kidney cancer.

1 Nov 2012

Watson acquires Actavis

Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of the Actavis Group for EUR 4.25 billion.

1 Nov 2012

Prognostic impact of Gleason score modernization undetermined

A review of contemporary grading systems for prostate cancer has found that modernization of the Gleason grading system results in more accurate grading for radical prostatectomy than older systems.

31 Oct 2012

High vitamin D levels associated with protection against bladder cancer

High levels of vitamin D are associated with protection against bladder cancer, according to a multidisciplinary study coordinated by molecular biologists and epidemiologists from the Spanish National Cancer Research Centre (CNIO), the conclusions of which are being published today in the Journal of National Cancer Institute (JNCI) .

31 Oct 2012

Sequana Medical announces CE mark approval of alfapump for patients with malignant ascites

Sequana Medical is pleased to announce that it has received CE mark approval for use of its alfapump system in patients with ascites caused by cancer (malignant ascites).

30 Oct 2012

Urology News and Research

Latest Urology News and Research

EMUC discusses current and future prospects in imaging for prostate cancer

Loyola explores different prostate cancer websites for meaningful medical information

Healthy ‘visual diet’ may help prevent eating disorders

Adrenoreceptor shows potential in overactive bladder treatment

Fasting before lipid testing may no longer be necessary

National Association For Continence to host free educational events from Nov. 12 - 16

Duration of ibuprofen use may reduce risk of bladder cancer in northern New England patients

Study addresses cost of patient care in acute care surgical settings

Taiho Pharmaceutical announces early stage data for eight novel oncology compounds

Monoclonal antibody boosts cholesterol reduction

Endo, Bioniche decide to end second Urocidin Phase III trial on non-muscle-invasive bladder cancer

Men with prostate cancer can benefit from active surveillance

Toilet training method not related to urinary accidents in children

Imatinib mesylate effectively treats children with neurofibromatosis type 1 tumors

Multiple sclerosis disease activity reduced by leukaemia drug, even when first-line treatment has failed

Encouraging results from stereotactic radiosurgery Phase I trial on kidney cancer

Watson acquires Actavis

Prognostic impact of Gleason score modernization undetermined

High vitamin D levels associated with protection against bladder cancer

Sequana Medical announces CE mark approval of alfapump for patients with malignant ascites

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Urology News and Research

Latest Urology News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in